Towa Pharmaceutical Co., Ltd. (4553)
Market Closed
10 Aug, 06:00
¥
3,705. 00
-245
-6.2025%
¥
160.73B Market Cap
- P/E Ratio
80% Div Yield
209,100 Volume
- Eps
¥ 3,950
Previous Close Want to track 4553 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Towa Pharmaceutical Co., Ltd. (4553) Statistics
Valuation metrics
Market Cap 160.73B
Enterprise value 375.88B
Trailing P/E (ttm) 37.04
Forward P/E 13.11
PEG ratio -0.51
Price/Sales (ttm) 0.71
Price/Book (mrq) 1.09
Enterprise Value/Revenue 1.37
Enterprise Value/EBITDA 9.82
Overview
Shares outstanding 49.23M
Float 23.01M
Shares short -
% Held by insiders 0.48%
% Held by institutions 0.2%
Average volume (10 days) 119.09K
Average volume (90 days) 152.55K
Price summary
52-Week low 2,764
52-Week high 4,490
Beta -0.3
50-Day moving average 3,997.71
200-Day moving average 3,966.91
Dividends and splits
Forward annual dividend rate 80
Forward annual dividend yield 0.0207%
Trailing annual dividend rate 80
Trailing annual dividend yield 0.0203%
5-Year annual dividend yield 2.29%
Payout ratio 0.75
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 3:1
Last split Date 27 Mar 2019
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.02%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.03%
Income Statement
Revenue (ttm) 273.71B
Revenue per share (ttm) 5,560.05
Quarterly revenue growth (yoy) 0.06%
Gross profit (ttm) 99.1B
EBITDA 46.62B
Net income to common (ttm) 5.25B
Diluted EPS (ttm) 106.65
Quarterly earnings growth (yoy) 0.1%
Balance Sheet
Total cash (mrq) 45.31B
Total cash per share (mrq) 920.33
Total debt (mrq) 228.95B
Total Debt/Equity (mrq) 1.27
Current ratio (mrq) 2.76%
Book value per share (mrq) 3,618.02
Cash Flow
Cash flow statement 30.43B
Levered free cash flow (LFCF) -2.86B
